Bifurcation PCI in a Patient on Oral Anticoagulation
A 74-year-old man with permanent atrial fibrillation (CHA2DS2-VASc 5) on apixaban 5 mg twice daily presents with stable angina CCS III. Coronary angiography shows a Medina 1,1,1 bifurcation lesion in the mid-LAD involving a large diagonal (reference vessel diameters: LAD 3.0 mm, diagonal 2.5 mm). Syntax score is 18. Left ventricular ejection fraction is 55%, and eGFR is 52 mL/min/1.73 m². The heart team recommends PCI. The patient is adamant about avoiding long-term dual antiplatelet therapy if possible and asks about dropping his anticoagulant. He has no prior bleeding history, and HAS-BLED is 2.
1. Which stenting strategy would you choose for this Medina 1,1,1 bifurcation, and how do you justify it against a provisional single-stent approach?
Read the worked answer
A two-stent strategy (provisional-first with a planned bailout, or upfront DK-crush/TAP if the side branch is truly large and diseased) is reasonable here because both the main vessel and side branch have significant disease (Medina 1,1,1) and the diagonal is large (≥2.5 mm) with a long diseased segment.
Key reasoning:
- Provisional approach remains default for most bifurcations, but when the side branch has ostial disease extending >5 mm and a reference diameter ≥2.5 mm, the risk of side-branch occlusion or restenosis after main-vessel stenting is meaningful. A planned two-stent technique (e.g., DK-crush) gives better side-branch ostial coverage and reduces the need for repeat intervention.
- Syntax score 18 falls in the low-intermediate range where PCI is acceptable, but bifurcation complexity still argues for a durable result.
- Anticoagulation burden matters: a two-stent technique often requires more aggressive post-dilation and longer DAPT, which interacts with his AF anticoagulation.
- Practical answer: attempt provisional stenting first with a strategy to convert to two-stent if the side branch pinches or has residual ostial disease; if you anticipate difficulty, plan DK-crush upfront. Either way, the decision should be documented and the patient consented for both.
2. How would you manage his antithrombotic regimen after PCI, and how do you address his request to stop anticoagulation?
Read the worked answer
He has AF with CHA2DS2-VASc 5 and HAS-BLED 2 - anticoagulation should continue. The question is how to combine it with antiplatelet therapy.
- Triple therapy is short and limited: give aspirin + clopidogrel + apixaban for the shortest period compatible with the stent complexity (typically 1 month for a simple PCI; up to 1–3 months for a complex bifurcation), then drop to dual therapy with apixaban + clopidogrel for 12 months, then apixaban alone.
- Prefer a P2Y12 inhibitor over aspirin in the dual-therapy phase (clopidogrel is preferred over ticagrelor/prasugrel in AF patients on anticoagulation because of bleeding risk).
- Dose considerations: apixaban 5 mg BID is appropriate given age and eGFR; avoid NSAIDs and monitor renal function.
- Address his request directly: stopping anticoagulation would expose him to a stroke risk that outweighs the bleeding risk from a short triple-therapy window. Explain that the modern approach minimizes the duration of triple therapy and that dual therapy (anticoagulant + one antiplatelet) is the standard after the initial period.
- If bleeding occurs, de-escalate to dual therapy early or switch to apixaban 2.5 mg BID only if criteria are met, and consider gastroprotection with a PPI.
3. What intravascular imaging or physiologic guidance would you use, and what would change your plan?
Read the worked answer
Imaging: IVUS or OCT of both the main vessel and side branch before and after stenting. In a Medina 1,1,1 lesion, imaging helps define the true carina, plaque distribution, and the side-branch ostium. Post-stent, imaging confirms stent expansion (minimum stent area targets: LAD ≥5.0 mm², side branch ≥4.0 mm²), malapposition, and edge dissection.
Physiology: FFR/iFR of the side branch after main-vessel stenting if the angiographic result is borderline; a side-branch FFR >0.80 suggests no further intervention is needed. Pre-PCI, FFR of the main vessel confirms ischemia if the angiogram is ambiguous.
What would change the plan:
- If imaging shows the side-branch ostium is spared or the carina is not involved, a provisional single-stent approach is sufficient.
- If post-stent imaging shows side-branch ostial compromise with FFR <0.80, proceed to two-stent or kissing-balloon optimization.
- If imaging reveals severe calcification, consider atherectomy before stenting to ensure expansion.